A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C) protocol for a prospective treatment registry of real world o

Article

Ramsay, J., Marsh, J., Pedrana, A., Andric, N., Norman, R., Cheng, W., Webb, S., Zeps, N., Bellgard, M., Graves, T., Hellard, M. and Snelling, T. 2020. A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C) protocol for a prospective treatment registry of real world o. BMC Infectious Diseases. 20 (Art. 802). https://doi.org/10.1186/s12879-020-05531-4
AuthorsRamsay, J., Marsh, J., Pedrana, A., Andric, N., Norman, R., Cheng, W., Webb, S., Zeps, N., Bellgard, M., Graves, T., Hellard, M. and Snelling, T.
Abstract

Background
Safe, highly curative, short course, direct acting antiviral (DAA) therapies are now available to treat chronic hepatitis C. DAA therapy is freely available to all adults chronically infected with the hepatitis C virus (HCV) in Australia. If left untreated, hepatitis C may lead to progressive hepatic fibrosis, cirrhosis and hepatocellular carcinoma. Australia is committed to eliminating hepatitis as a public health threat by 2030 set by the World Health Organization. However, since the introduction of funded DAA treatment, uptake has been suboptimal. Australia needs improved strategies for testing, treatment uptake and treatment completion to address the persisting hepatitis C public health problem. PLATINUM C is a HCV treatment registry and research platform for assessing the comparative effectiveness of alternative interventions for achieving virological cure.

Methods
PLATINUM C will prospectively enrol people with active HCV infection confirmed by recent detection of HCV ribonucleic acid (RNA) in blood. Those enrolled will agree to allow standardised collection of demographic, lifestyle, treatment, virological outcome and other relevant clinical data to better inform the future management of HCV infection. The primary outcome is virological cure evidenced by sustained virological response (SVR), which is defined as a negative HCV PCR result 6 to 18 months after initial prescription of DAA therapy and no less than 12 weeks after the completion of treatment. Study participants will be invited to opt-in to medication adherence monitoring and quality of life assessments using validated self-reported instruments (EQ-5D-5L).

Discussion
PLATINUM C is a treatment registry and platform for nesting pragmatic trials. Data collected will inform the design, development and implementation of pragmatic trials. The digital infrastructure, study procedures and governing systems established by the registry will allow PLATINUM C to support a wider research platform in the management of hepatitis C in primary care.

Trial registration
The trial is registered with the Australia and New Zealand Clinical Trials Register (ACTRN12619000023156). Date of registration: 10/01/2019.

JournalBMC Infectious Diseases
Journal citation20 (Art. 802)
ISSN1471-2334
Year2020
PublisherBioMed Central
Publisher's version
License
File Access Level
Anyone
Supplemental file
File Access Level
Anyone
Digital Object Identifier (DOI)https://doi.org/10.1186/s12879-020-05531-4
Publication dates
Online29 Oct 2020
Publication process dates
Accepted20 Oct 2020
Deposited02 May 2023
Funder Government of Western Australia, Department of Health Research Translation Projects (RTP)
Copyright holder© 2020, The Authors
Permalink -

https://repository.uel.ac.uk/item/8vyy8

Log in to edit

Download files

Publisher's version
A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C) - protocol for a prospective treatment registry of real-world o.pdf
License: CC BY 4.0
File access level: Anyone

Supplemental file
Supplementary File 1 - Life Style Questionnaire.pdf
File access level: Anyone

  • 75
    total views
  • 48
    total downloads
  • 1
    views this month
  • 1
    downloads this month

Export as

Related outputs

RDM+PM Checklist: Towards a Measure of Your Institution’s Preparedness for the Effective Planning of Research Data Management
Bellgard, M., Bennett, R., Wyborn, Y., Williams, C., Barner, L. and Zeps, N. 2023. RDM+PM Checklist: Towards a Measure of Your Institution’s Preparedness for the Effective Planning of Research Data Management. Data Science Journal. 22 (Art. 36). https://doi.org/10.5334/dsj-2023-036
Genome architecture and diverged selection shaping pattern of genomic differentiation in wild barley
Zhang, W., Tan, C., Hu, H., Pan, R., Xiao, Y., Ouyang, K., Zhou, G., Jia, Y., Zhang, X-Q., Hill, C. B., Wang, P., Chapman, B., Han, Y., Xu, L., Xu, Y., Angessa, T., Luo, H., Westcott, S., Sharma, D., Nevo, E., Barrero, R. A., Bellgard, M. I., He, T., Tian, X. and Li, C. 2023. Genome architecture and diverged selection shaping pattern of genomic differentiation in wild barley. Plant Biotechnology Journal. 21 (1), pp. 46-62. https://doi.org/10.1111/pbi.13917
TEDD: a database of temporal gene expression patterns during multiple developmental periods in human and model organisms
Zhou, Z., Tan, C., Chau, M. H. K., Jiang, X., Ke, Z., Chen, X., Cao, Y., Kwok, Y. K., Bellgard, M., Leung, T. Y., Choy, K. W. and Dong, Z. 2023. TEDD: a database of temporal gene expression patterns during multiple developmental periods in human and model organisms. Nucleic Acids Research. 51 (D1), pp. D1168-D1178. https://doi.org/10.1093/nar/gkac978
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria
Mu, A., Klare, W. P., Baines, S. L., Ignatius Pang, C. N., Guérillot, R., Harbison-Price, N., Keller, N., Wilksch, J., Nhu, N. T. K., Phan, M-D., Keller, B., Nijagal, B., Tull, D., Dayalan, S., Chua, H. H. C., Skoneczny, D., Koval, J., Hachani, A., Shah, A. D., Neha, N., Jadhav, S., Partridge, S. R., Cork, A. J., Peters, K., Bertolla, O., Brouwer, S., Hancock, S. J., Álvarez-Fraga, L., De Oliveira, D. M. P., Forde, B., Dale, A., Mujchariyakul, W., Walsh, C. J., Monk, I., Fitzgerald, A., Lum, M., Correa-Ospina, C., Roy Chowdhury, P., Parton, R. G., De Voss, J., Beckett, J., Monty, F., McKinnon, J., Song, X., Stephen, J. R., Everest, M., Bellgard, M. I., Tinning, M., Leeming, M., Hocking, D., Jebeli, L., Wang, N., Ben Zakour, N., Yasar, S. A., Vecchiarelli, S., Russell, T., Zaw, T., Chen, T., Teng, D., Kassir, Z., Lithgow, T., Jenney, A., Cole, J. N., Nizet, V., Sorrell, T. C., Peleg, A.Y., Paterson, D. L., Beatson, S. A., Wu, J., Molloy, M. P., Syme, A. E., Goode, R. J. A., Hunter, A. A., Bowland, G., West, N. P., Wilkins, M. R., Djordjevic, S. P., Davies, M. R., Seemann, T., Howden, B. P., Pascovici, D., Tyagi, S., Schittenhelm, R. B., De Souza, D. P., McConville, M. J., Iredell, J. R., Cordwell, S. J., Strugnell, R. A., Stinear, T. P., Schembri, M. A. and Walker, M. J. 2023. Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria. Nature Communications. 14 (Art. 1530). https://doi.org/10.1038/s41467-023-37200-w
Association between early and current gastro-intestinal symptoms and co-morbidities in children and adolescents with Angelman syndrome
Leader, G., Whelan, S., Chonaill, N. N., Coyne, R., Tones, M., Heussler, H., Bellgard, M. and Mannion, A. 2022. Association between early and current gastro-intestinal symptoms and co-morbidities in children and adolescents with Angelman syndrome. Journal of Intellectual Disability Research. 66 (11), pp. 865-879. https://doi.org/10.1111/jir.12975
An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry
Roche, L., Tones, M., Cross, M., Bellgard, M. and Heussler, H. 2022. An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry. Advances in Neurodevelopmental Disorders. 6 (4), pp. 442-455. https://doi.org/10.1007/s41252-022-00278-2
Immunomic Investigation of Holocyclotoxins to Produce the First Protective Anti-Venom Vaccine Against the Australian Paralysis Tick, Ixodes holocyclus
Rodriguez-Valle, M., McAlister, S., Moolhuijzen, P. M., Booth, M., Agnew, K., Ellenberger, C., Knowles, A. G., Vanhoff, K., Bellgard, M. I and Tabor, A. E. 2021. Immunomic Investigation of Holocyclotoxins to Produce the First Protective Anti-Venom Vaccine Against the Australian Paralysis Tick, Ixodes holocyclus. Frontiers in Immunology. 12 (Art. 744795). https://doi.org/10.3389/fimmu.2021.744795
BarleyVarDB: a database of barley genomic variation
Tan, C., Chapman, B., Wang, P., Zhang, Q., Zhou, G., Zhang, X-Q., Barrero, R. A., Bellgard, M. I. and Li, C. 2020. BarleyVarDB: a database of barley genomic variation. Database. (Art. baaa091). https://doi.org/10.1093/database/baaa091
ERDMAS: An exemplar-driven institutional research data management and analysis strategy
Bellgard, M. I. 2020. ERDMAS: An exemplar-driven institutional research data management and analysis strategy. International Journal of Information Management. 50, pp. 337-340. https://doi.org/10.1016/j.ijinfomgt.2019.08.009